Αρχική World News Tables Turned

Tables Turned

As the Chair of the Department of Radiation Oncology at Penn, I have never felt prouder of our incredibly devoted staff and faculty. They have stepped up as a group from the very beginning of this global COVID crisis and forged new paths. Our collective expertise and comfort working as a team to deliver the safest and most effective treatment to our patients has been in place from day one and will continue as we start our resurgence as a health system. I am certainly not alone in feeling pride about my colleagues, as the response from dedicated healthcare providers across the country has been inspiring.

Jim Metz, MD

When I talk about my pride in this team, I’m not just thinking about how things have changed from pre-pandemic to post-pandemic in the clinic and research. I also have a very personal before and after from right around the same time.

When I think back just a few months ago, pre-pandemic, I experienced a completely different vantage point. I was sitting in the waiting room. I sat in the seat in an exam room waiting for a physician. I watched in the hallway as the light flashed “beam on.” I was a caregiver. My father was diagnosed with colorectal cancer in December 2019, and the tables radically turned, as did my perspective. Little did I know, in all the years I worked on bringing this treatment center to reality, that eventually my father was going to benefit from treatment here.

As I met my dad each day during his treatment, I saw my work environment and team through new eyes. I felt supported by the compassion and kindness of every person who took care of my dad along the way. I felt a renewed appreciation for the team and their incredible expertise in caring for cancer patients. There was a great amount of pride and confidence I felt knowing that my dad was receiving the best treatment possible. Through the ups and downs, the expertise and support that was provided to my dad and my family was simply exceptional. It gave him the strength to fight through some difficult moments, and I am happy to say that he has completed his treatments and continues to rest at home comfortably. I will never forget how it feels to sit on the other side as a caregiver, watching my loved one go through the fight of his life.

This is a profoundly challenging time for all of us, as there is so much uncertainty and a lot of changing information on a daily basis. It has been a source of great pride to lead a department that is so resilient, collaborative, and innovative. My awareness about the power of healthcare providers was heightened as I became a caregiver and has been repeatedly confirmed through the challenging times that COVID-19 has brought. All of the thanks that I have received from patients and family members over the years about our staff suddenly crystalized through this experience. We really do have an incredible team and I have been blessed to see that from both sides of the fence. I am humbled to say that I bring that to my daily work.


James M. Metz, MD, is the Henry K. Pancoast Professor and Chair of Radiation Oncology and director of the Roberts Proton Therapy Center at the Abramson Cancer Center. He is also the Executive Director of OncoLink and has been writing, leading and serving as a champion of the OncoLink mission for over 25 years.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant Chemotherapy

The ECOG-ACRIN EA1131 study hypothesised that invasive disease-free survival (iDFS) would not be inferior but improved in patients with basal subtype triple-negative breast cancer...

How Does CAR T-Cell Therapy Work in Treating Cancer?

Craig A. Portell, MD, is an Associate Professor of Medicine at the University of Virginia and a member of the UVA Cancer Center in...

Nivolumab-Based Combinations Improve Survival in Advanced Esophageal Cancer

June 17, 2021, by NCI Staff An x-ray of the esophagus and upper gastrointestinal tract following a barium swallow test.  Credit: iStock For some people with advanced...

Wales: 4 in 10 with possible cancer symptoms didn’t contact GP

New figures show 42.1% of people surveyed in Wales who experienced possible cancer symptoms in the first wave of the pandemic didn’t contact their...

Survey Shows Oncologists Underestimate How Many Cancer Patients Use Alternative Therapies

Many cancer patients use alternative or complementary therapies in conjunction with their main course of treatment, but a new survey shows that many oncologists...

Ground-breaking trial pilots new tests to detect lung cancer earlier

Credit: Southampton Clinical Trials Unit The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer...